Utility of the optical quality analysis system for decision-making in Nd: YAG laser posterior capsulotomy in patients with light posterior capsule opacity

BackgroundA prospective cohort study was performed to evaluate whether the Optical Quality Analysis System (OQAS) can serve as a valuable additional indicator for appropriate posterior capsulotomy referral.MethodsOne hundred and five eyes from 96 patients undergoing capsulotomy were divided into precapsulotomy logMAR CDVA <= 0.1 group and logMAR CDVA >0.1 group. CDVA, and the Visual Function 14 index (VF-14) score were estimated before and 1month after capsulotomy. The objective scattering index (OSI) value was measured by using the OQAS. Posterior capsule opacification (PCO) severity was assessed with Evaluation of PCO 2000 (EPCO 2000) software.ResultsIn logMAR CDVA >0.1 group, the correlations of OSI, logMAR CDVA, EPCO score and VF-14 score were very strong preoperatively. In logMAR CDVA <= 0.1 group, preoperatively, OSI was correlated with logMAR CDVA (r=0.451), EPCO score (r=0.789), and VF-14 score (r=0.852). LogMAR CDVA has weak correlation with VF-14 score (r=-0.384) and EPCO score (r=0.566). VF-14 score was correlated with EPCO score (r=-0.669). In the logMAR CDVA <= 0.1 group, there was no significant difference in logMAR CDVA between precapsulotomy and postcapsulotomy (P>0.05). In the two groups, all the other optical quality parameters were significantly improved after capsulotomy (P<0.05). In logMAR CDVA >0.1 group, the area under the curve of the ROC of the OSI was 0.996 (P=0.000). In logMAR CDVA <= 0.1 group, the area under the curve of the ROC of the OSI was 0.943 (P=0.000).ConclusionsThe OSI was useful for evaluating of PCO and prediction of beneficial capsulotomy. Especially for patients with slight PCO and better visual acuity, OSI is more valuable than CDVA and completely objective examination.Trial registrationThe study protocol was registered at the Chinese Clinical Trial Registry. Register: ChiCTR1800018842 (Registered Date: October 13th, 2018).